For the quarter ending 2026-03-31, ASRT had $23,484K increase in cash & cash equivalents over the period.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Impairment of intangible assets | - | 1,700 | - | - |
| Loss on assertio therapeutics divestiture | - | 0 | 0 | -8,174 |
| Net loss | -18,856 | -11,927 | 11,445 | -29,893 |
| Depreciation and amortization | 5,840 | 5,839 | 5,630 | 18,536 |
| Amortization of debt issuance costs | 125 | 122 | 120 | 233 |
| Impairment of intangible assets | - | - | 1,700 | - |
| Accretion of interest income from short-term investments | -180 | -49 | -8 | -36 |
| Recurring fair value measurements of assets and liabilities | -30 | 167 | 302 | -34 |
| Payment of contingent consideration | - | 450 | - | - |
| Provisions for inventory | 198 | 1,313 | 522 | 2,675 |
| Stock-based compensation | 725 | 97 | 1,067 | 2,290 |
| Accounts receivable | -58,583 | -21,197 | 80,217 | 6,970 |
| Inventories | -912 | 670 | -7,595 | -2,753 |
| Prepaid and other assets | 1,698 | 4,896 | -14,017 | 7,912 |
| Accounts payable and other accrued liabilities | 196 | -9,955 | -10,351 | 7,014 |
| Accrued rebates, returns and discounts | -37,022 | -31,170 | 44,649 | 9,583 |
| Interest payable | 0 | - | -650 | - |
| Net cash provided by (used in) operating activities | 8,563 | -29,968 | -4,767 | 6,553 |
| Assertio therapeutics divestiture | - | 0 | 0 | 8,174 |
| Proceeds from maturities of short-term investments | 30,368 | 30,151 | 27,660 | 57,572 |
| Purchases of short-term investments | 15,258 | 28,452 | 31,472 | 59,273 |
| Net cash provided by (used in) investing activities | 15,110 | 1,699 | -3,812 | -9,875 |
| Payments related to the vesting and settlement of equity awards | 189 | 2 | 7 | 180 |
| Net cash used in financing activities | -189 | -2 | -7 | -180 |
| Net increase (decrease) in cash and cash equivalents | 23,484 | -28,271 | -8,586 | -3,502 |
| Cash and cash equivalents at beginning of year | 10,229 | 38,500 | 50,588 | - |
| Cash and cash equivalents at end of period | 33,713 | 10,229 | 38,500 | - |